> ## Content Index > Fetch the complete content index at: https://www.thepeptidereview.co/llms.txt > Use this file to discover other available public pages before exploring further. # Semax: Research Background and Overview - URL: https://www.thepeptidereview.co/semax-research-background-and-overview/ - Published: 2026-08-21T01:00:00.000Z - Updated: 2026-09-15T01:18:24.000Z - Author: michael burbano - Tags: Mechanism Explainers Semax is one of the most-studied synthetic peptides to come out of Russian neuropeptide research, yet it remains largely unknown in the West. This overview covers what Semax is, where it came from, what the published literature has actually examined, and how researchers evaluate the quality of a reference sample. It is written for a research audience and makes no health, therapeutic, or performance claims. ## What Semax is Semax is a short synthetic peptide — a heptapeptide, meaning it is built from seven amino acids. Its sequence is **Pro-Gly-Pro** added to a fragment of a naturally occurring hormone, giving the full sequence **Met-Glu-His-Phe-Pro-Gly-Pro**. That structure is not arbitrary. The first four residues (Met-Glu-His-Phe) correspond to the **4–7 fragment of adrenocorticotropic hormone (ACTH)**, a well-characterized signaling molecule. On its own, that fragment is broken down in the body within minutes. Russian researchers attached the **Pro-Gly-Pro** "tail" specifically to slow enzymatic degradation, which is what turned a fleeting fragment into a molecule stable enough to study. This is a recurring theme in peptide chemistry: small sequence modifications made to control stability, not to add a new biological "ingredient." Because the ACTH(4–7) core is the melanocortin fragment *without* the portion responsible for the parent hormone's classic endocrine (cortisol-releasing) activity, Semax is described in the literature as a fragment analog that was designed to separate one property of the parent molecule from the rest. ## Where it came from Semax was developed in the 1980s at the **Institute of Molecular Genetics of the Russian Academy of Sciences**, in collaboration with Moscow State University. It is one of a small family of "regulatory peptide" analogs — Selank, another peptide frequently discussed alongside Semax, came out of the same research program and a related design philosophy. Semax has been listed on Russia's register of essential medicines, which is why a substantial fraction of the human literature originates from Russian-language clinical journals. Outside of Russia and a few neighboring countries it has **no regulatory approval**, and Western regulators (including the U.S. FDA) have **not** evaluated or approved it for any use. For that reason, essentially all Western-accessible material is either preclinical (cell and animal studies) or falls under laboratory research use — a distinction worth keeping front of mind when reading claims online. ## What the published research has examined The scientific interest in Semax centers on the **nervous system**. Rather than list outcomes, it is more accurate to describe the *categories* of question researchers have investigated: - **Neurotrophic signaling.** Several preclinical studies have measured whether Semax exposure changes expression of **BDNF (brain-derived neurotrophic factor)** and its receptor TrkB in cultured neurons and rodent hippocampus. BDNF is a protein involved in neuron growth and survival, and it is a common readout in neuropharmacology research. - **The melanocortin and neuropeptide systems.** Because of its ACTH-fragment origin, Semax has been studied as a probe for how melanocortin-fragment peptides interact with neural tissue without triggering the parent hormone's steroidogenic pathway. - **Gene-expression profiling.** More recent work has used transcriptome-wide analyses to catalog which genes change expression in nervous tissue following Semax exposure in animal models — a data-generating, mechanism-mapping exercise rather than an outcome trial. - **Ischemia models.** A portion of the Russian clinical literature examined Semax in the context of acute cerebrovascular events. These studies are frequently cited but vary widely in size and methodology, and have not been replicated in the large, blinded, Western-standard trials that regulators require. None of this establishes a benefit for any use in humans, and this article is not asserting one. The point is narrower: Semax is a genuine object of peer-reviewed neuropeptide research, and understanding *what* that research measures is the difference between reading the science and reading the marketing. ## Forms you'll encounter In the research-materials market, [Semax](https://novaforgelabs.co/product.html?id=17&ref=thepeptidereview.co) is supplied as a research-use-only reference material in two physical forms: - **Lyophilized (freeze-dried) powder** in a sealed vial — the most stable form for storage and the standard for laboratory handling. It is reconstituted with bacteriostatic water before use. - **Nasal solution** — a pre-mixed liquid. Intranasal delivery is common in the peptide literature because it is the route most studied for this compound, but a pre-mixed liquid is inherently less shelf-stable than a sealed lyophilized vial and has stricter storage requirements once opened. Neither form implies any approved application; the format simply reflects how the compound is handled in a lab setting. ## How a research sample's quality is evaluated For a short synthetic peptide, "is it real, and is it what the label says" is answered by analytical chemistry, not by brand claims. The two documents that matter: 1. **A third-party Certificate of Analysis (COA) tied to the specific lot.** Sequence and manufacturer claims mean nothing if they don't correspond to the vial in hand. A COA should reference the lot number printed on that vial. 2. **HPLC purity data.** High-performance liquid chromatography separates a sample into its components and reports the target peptide as a percentage of the total. A single clean dominant peak at high purity is what you want to see; a cluster of smaller peaks indicates synthesis byproducts or degradation. If you want the mechanics of reading these documents, see our companion piece on [how to read a Certificate of Analysis](https://www.thepeptidereview.co/how-to-read-a-coa) — it walks through what each number on an HPLC report actually means. ## Storage, in general terms Peptide stability is a chemistry question, and the honest short answer is: **a sealed lyophilized vial is far more forgiving than a reconstituted or pre-mixed solution.** Freeze-dried powder kept cold and dark degrades slowly; once a peptide is in water, hydrolysis and other reactions proceed much faster, which is why liquid and reconstituted forms carry shorter, colder storage windows. Manufacturer and lot-specific guidance always supersedes general rules of thumb. We cover the underlying chemistry in [how to store peptides](https://www.thepeptidereview.co/how-to-store-peptides). ## Frequently asked questions **Is Semax approved by the FDA?** No. It has no U.S. or Western regulatory approval and has not been evaluated by those agencies. Its approvals are limited to Russia and a few neighboring countries. **How is Semax different from Selank?** They come from the same Russian research program but are different molecules with different sequences and different research literatures. We compare them directly in a separate article. **What does the "ACTH fragment" origin mean?** Semax's core four amino acids match a fragment of the ACTH hormone — but deliberately the fragment *without* the part that drives ACTH's classic cortisol-releasing activity. It was designed to isolate one property from the parent molecule. **Why is so much of the research in Russian?** Because Semax was developed and is registered as a medicine in Russia, most of the human-subject literature was published in Russian-language clinical journals. Western-accessible work is largely preclinical. ## References 1. Ashmarin IP, et al. *Design and study of the regulatory peptide Semax.* Institute of Molecular Genetics, Russian Academy of Sciences. 2. Dolotov OV, et al. "Semax, an analog of ACTH(4–10), regulates BDNF and trkB expression in the rat hippocampus." *Journal of the Neurological Sciences.* 3. Medvedeva EV, et al. "Gene expression changes in the rat brain following Semax administration." *Journal of Molecular Neuroscience.* 4. Shevchenko KV, et al. "Stability and degradation of Semax and related proline-containing peptides." *Russian Journal of Bioorganic Chemistry.* *References are provided for background reading and do not constitute endorsement of any use.* --- *The Peptide Review publishes educational summaries of the scientific literature. Nothing here is medical advice, and nothing here describes a use for any product. Compounds discussed are reference materials for qualified in-vitro laboratory research only and are not drugs, supplements, or products for human or animal consumption.* 🧪 Free research tools [COA Checker →](https://thepeptidereview.co/peptide-coa-checker/?ref=thepeptidereview.co) — audit a Certificate of Analysis & spot forged/recycled COAs [Reconstitution Calculator →](https://thepeptidereview.co/peptide-reconstitution-calculator/?ref=thepeptidereview.co) — exact draw in units + mL, on a to-scale syringe [Stability & Shelf-Life Estimator →](https://thepeptidereview.co/peptide-stability-shelf-life-estimator/?ref=thepeptidereview.co) — how integrity holds up in the freezer, fridge & at room temp Research Use Only ### Source the compounds covered here The reference materials discussed above are supplied for qualified in-vitro laboratory research only — third-party HPLC-tested with a Certificate of Analysis per lot. [Browse tested research compounds →](https://novaforgelabs.co/?ref=thepeptidereview.co) The Peptide Review is published with support from NovaForge Labs. See our [Disclosures](https://www.thepeptidereview.co/disclosures-disclaimer/). Subscriber offer ### Get 20% off your first order Subscribe to The Peptide Review and we will send your NovaForge Labs discount code, plus each new research breakdown as it is published. No spam. [Subscribe for 20% off →](#/portal/signup)